Mural Oncology plc
Mural Oncology plc (MURA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · MURA · as of Jun 8, 2026
Key Statistics
Explore Mural Oncology plc Data
mura stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 50.0%
Competitors & Peers
mura competitorsMURA
ATHE
BCAB
BTAI
EVAX
GBIOStock Performance
Full HistoryAbout Mural Oncology plc
Mural Oncology plc a clinical-stage company, is dedicated to discovering and advancing immune-based therapies for individuals battling cancer. Its primary drug candidate, nemvaleukin alfa, is current…
what is mural oncology plc · mura stock overview · mural oncology plc company profile · who is mural oncology plc ceo · mura NASDAQ · mural oncology plc headquarters · mural oncology plc business segments
About Stock Overview & Key Data
Mural Oncology plc (MURA) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Nov 16, 2023. As of the latest trading session, MURA stock price is $2.04, with a market capitalization of $35.4M. The stock has returned -44.11% over the past 12 months and +0.00% year-to-date.
According to 2 Wall Street analysts, the consensus rating for Mural Oncology plc stock is Buy, with an average 12-month price target of $—. In fiscal year 2024, Mural Oncology plc reported revenue of — and net income of -$128.5M. For detailed data — including Mural Oncology plc revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Mural Oncology plc (MURA) stock price is $2.04. The stock is traded on NASDAQ under the ticker symbol MURA. The 52-week range is $0.95 – $4.74.